TASMAN PHARMA FDA Approval ANDA 213661

ANDA 213661

TASMAN PHARMA

FDA Drug Application

Application #213661

Application Sponsors

ANDA 213661TASMAN PHARMA

Marketing Status

Prescription001

Application Products

001UNKNOWNUNKNOWN2DROXIDOPADROXIDOPA

FDA Submissions

UNKNOWN; ORIG1TA2020-12-04STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

TASMAN PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213661
            [companyName] => TASMAN PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DROXIDOPA","activeIngredients":"DROXIDOPA","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/04\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-12-04
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.